Comparative effects of sulfones and rifampin on growth of Mycobacterium lepraemurium in macrophage diffusion chamber cultures

A cell-impermeable diffusion chamber technique has been developed that lends itself to growth studies of Mycobacterium lepraemurium. This technique, in which the organism grows within macrophage cultures inside the chambers that are maintained on monolayer cultures of macrophages, provides a method for a strict in vitro evaluation of antileprosy drugs without the influence of a multiplicity of host factors. This system was used to compare the effect of three sulfone derivatives and rifampin on the growth of M. lepraemurium within these diffusion chamber cultures. Two sulfones, 4,4'-diaminodiphenyl sulfone and 4,4'-diacetamidodiphenyl sulfone, as well as rifampin, suppressed the growth of M. lepraemurium, but monoacetyl sulfone 4-amino-4'acetamidodiphenyl sulfone had no effect. The results indicate that the diffusion chamber technique can be used to evaluate the inhibitory effect of antileprosy drugs on the growth of M. lepraemurium. Also, the method provides for the first time a relatively rapid in vitro method for directly comparing the effects of drugs or their analogs when outside the metabolic influence of an animal host. This technique may be a useful tool for chemotherapy studies with other antileprosy compounds.

[1]  J. Biggs,et al.  Disposition of Dapsone and Monoacetyldapsone in Rats 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  L. Levy,et al.  The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS). , 1972, The American journal of tropical medicine and hygiene.

[3]  J. Biggs,et al.  Disposition of the Antileprosy Drug, Dapsone, in the Mouse 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  J. Murray,et al.  A chromatographic-fluorometric procedure for the determination of nanogram quantities of antileprotic sulfones. , 1971, The Journal of laboratory and clinical medicine.

[5]  A. Glazko,et al.  The polymorphic acetylation of dapsone in man , 1971, Clinical pharmacology and therapeutics.

[6]  W. Rightsel,et al.  Growth of Mycobacterium lepraemurium in Cell-Impermeable Diffusion Chambers , 1971, Infection and immunity.

[7]  R. Rees,et al.  Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy , 1970, British medical journal.

[8]  Y. T. Chang,et al.  Suppressive activity of streptomycin on the growth of Mycobacterium lepraemurium in macrophage cultures. , 1969, Applied microbiology.

[9]  B. Argyris ROLE OF MACROPHAGES IN IMMUNOLOGICAL MATURATION , 1968, The Journal of experimental medicine.

[10]  D. H. McRae,et al.  The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy. , 1968, The American journal of tropical medicine and hygiene.

[11]  R. Rees,et al.  Limited Multiplication of M. lepraemurium in Tissue Culture , 1958, Nature.

[12]  R G COCHRANE,et al.  Chemotherapy of Leprosy* , 1952, The Practitioner.

[13]  J. Murray,et al.  Acedapsone treatment of leprosy patients: response versus drug disposition. , 1977, The American journal of tropical medicine and hygiene.

[14]  D. H. McRae,et al.  A method for counting acid-fast bacteria. , 1968, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.